Download
s00345-021-03614-8.pdf 673,33KB
WeightNameValue
1000 Titel
  • The negative aftermath of prostate biopsy: prophylaxis, complications and antimicrobial stewardship: results of the global prevalence study of infections in urology 2010–2019
1000 Autor/in
  1. Alidjanov, Jakhongir |
  2. Cai, Tommaso |
  3. Bartoletti, Riccardo |
  4. Bonkat, Gernot |
  5. Bruyere, franck |
  6. Köves, Béla |
  7. , Ekaterina |
  8. Medina-Polo, José |
  9. Naber, Kurt |
  10. Perepanova, Tamara Sergeevna |
  11. Pilatz, Adrian |
  12. tandogdu, zafer |
  13. bjerklund johansen, truls erik |
  14. Wagenlehner, Florian |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-02-22
1000 Erschienen in
1000 Quellenangabe
  • 39(9):3423-3432
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00345-021-03614-8 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510929/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Purpose!#!To evaluate and report the complications, and to analyse antimicrobial stewardship aspects following prostate biopsies (P-Bx) based on the data from a 9-year global study.!##!Methods!#!The primary outcome was to compare complications after P-Bx between patients of two cohorts: 2010-2014 and 2016-2019. Primary outcomes included symptoms of lower and severe/systemic urinary tract infection (LUTIS and SUTIS, respectively), and positive urine culture. Readmission to hospital after P-Bx, need for additional antimicrobial therapy, consumption of different antimicrobial agents for prophylaxis and therapy were evaluated. Students t test and chi-square test were used for comparative analyses.!##!Results!#!Outcome data were available for 1615 men. Fluoroquinolones-based prophylaxis rate increased from 72.0% in 2010-2014 to 78.6% in 2015-2019. Overall rates of complications increased from 6 to 11.7% including an increase in symptomatic complications from 4.7 to 10.2%, mainly due to an increase in LUTIS. Rates of patients seeking additional medical help in primary care after P-Bx increased from 7.4 to 14.4%; cases requiring post P-Bx antibiotic treatment increased from 6.1 to 9.7%, most of which received fluoroquinolones. Transperineal P-Bx was significantly associated with LUTIS. Following transrectal P-Bx, 2.8% developed febrile infections and 4.0% required hospitalisation. Two men (0.12%) died after transrectal P-Bx due to sepsis.!##!Conclusions!#!The rates of complications after P-Bx tended to increase in time, as well as rates of patients seeking additional medical help in the post-P-Bx period. To reduce the risk of infectious complications and to comply with the principles of antibiotic stewardship, clinicians should switch to the transperineal biopsy route.
1000 Sacherschließung
lokal Antibiotic Prophylaxis [MeSH]
lokal Prostate biopsy
lokal Urinary Tract Infections/etiology [MeSH]
lokal Aged [MeSH]
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Urinary Tract Infections/prevention
lokal Middle Aged [MeSH]
lokal Cross-Sectional Studies [MeSH]
lokal Antimicrobial Stewardship [MeSH]
lokal Time Factors [MeSH]
lokal Original Article
lokal Male [MeSH]
lokal Postoperative Complications/prevention
lokal Prostate/pathology [MeSH]
lokal Biopsy/adverse effects [MeSH]
lokal Antibiotics
lokal Antibiotic resistance
lokal Fluoroquinolones
lokal Postoperative Complications/etiology [MeSH]
lokal Global Health [MeSH]
lokal Prostate cancer
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-2531-4877|https://orcid.org/0000-0002-7234-3526|https://orcid.org/0000-0002-0021-0302|https://orcid.org/0000-0002-7298-6468|https://orcid.org/0000-0002-9281-9421|https://orcid.org/0000-0001-6886-0750|https://orcid.org/0000-0001-7965-2711|https://orcid.org/0000-0003-3626-8669|https://orcid.org/0000-0003-1304-5403|https://orcid.org/0000-0002-2877-0029|https://orcid.org/0000-0001-8072-1841|https://orcid.org/0000-0002-5309-3656|https://orcid.org/0000-0003-3490-6460|https://orcid.org/0000-0002-2909-0797
1000 Hinweis
  • DeepGreen-ID: 5e0d307fc5484085b191b4afd1c439fa ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6451121.rdf
1000 Erstellt am 2023-05-11T12:15:59.787+0200
1000 Erstellt von 322
1000 beschreibt frl:6451121
1000 Zuletzt bearbeitet 2023-10-21T04:20:35.453+0200
1000 Objekt bearb. Sat Oct 21 04:20:35 CEST 2023
1000 Vgl. frl:6451121
1000 Oai Id
  1. oai:frl.publisso.de:frl:6451121 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source